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Abstract
Introduction: Severity assessment and site-of-care decisions for patients with community-acquired pneumonia
(CAP) are pivotal for patients’ safety and adequate allocation of resources. Late admission to the intensive care unit
(ICU) has been associated with increased mortality in CAP. We aimed to review and meta-analyze systematically
the performance of clinical prediction rules to identify CAP patients requiring ICU admission or intensive treatment.
Methods: We systematically searched Medline, Embase, and the Cochrane Controlled Trials registry for clinical trials
evaluating the performance of prognostic rules to predict the need for ICU admission, intensive treatment, or the
occurrence of early mortality in patients with CAP.
Results: Sufficient data were available to perform a meta-analysis on eight scores: PSI, CURB-65, CRB-65, CURB, ATS
2001, ATS/IDSA 2007, SCAP score, and SMART-COP. The estimated AUC of PSI and CURB-65 scores to predict ICU
admission was 0.69. Among scores proposed for prediction of ICU admission, ATS-2001 and ATS/IDSA 2007 scores
had better operative characteristics, with a sensitivity of 70% (CI, 61 to 77) and 84% (48 to 97) and a specificity of
90% (CI, 82 to 95) and 78% (46 to 93), but their clinical utility is limited by the use of major criteria.
ATS/IDSA 2007 minor criteria have good specificity (91% CI, 84 to 95) and moderate sensitivity (57% CI, 46 to 68).
SMART-COP and SCAP score have good sensitivity (79% CI, 69 to 97, and 94% CI, 88 to 97) and moderate
specificity (64% CI, 30 to 66, and 46% CI, 27 to 66). Major differences in populations, prognostic factor
measurement, and outcome definition limit comparison. Our analysis also highlights a high degree of
heterogeneity among the studies.
Conclusions: New severity scores for predicting the need for ICU or intensive treatment in patients with CAP, such
as ATS/IDSA 2007 minor criteria, SCAP score, and SMART-COP, have better discriminative performances compared
with PSI and CURB-65. High negative predictive value is the most consistent finding among the different prediction
rules. These rules should be considered an aid to clinical judgment to guide ICU admission in CAP patients.
Introduction
Community-acquired pneumonia (CAP) is a major health
problem. In the United States, 500,000 adults are hospita-
lized annually for CAP [1], of whom 10% to 20% are
admitted to the intensive care unit (ICU) [2]. Because site
of care is a major determinant of costs, clinical prediction
rules have been developed to identify patients with low
mortality who can be safely treated as outpatients [3].
Since 1993, efforts have been made to identify severe
community-acquired pneumonia (SCAP) requiring
admission to the ICU because the ICU is an expensive
and scarce resource. Concurrently, delay in ICU admis-
sion of CAP patients has been shown to be associated
with increased mortality [4-6]. In 1993, the American
Thoracic Society (ATS) proposed a definition of severe
CAP requiring ICU admission [7]. Since then, these cri-
teria have been updated twice [8,9], and various clinical
prediction rules have been developed to predict SCAP
[10-12]. In addition to the variety of the prediction rules,
the assessment of their validity is further hampered by
the absence of a unique definition of SCAP and the inclu-
sion of ICU admission or intensive treatment in the
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definition, which exposes prediction rules for SCAP to
incorporation bias [13].
The goal of our search was to review systematically
the performance of existing clinical prediction rules to
identify in the Emergency Department patients with
CAP requiring ICU admission or intensive treatment.
Materials and methods
Search strategy and study selection
We systematically searched Medline, Embase, and the
Cochrane Controlled Trials registry by using the follow-
ing key words: community-acquired pneumonia AND
(decision tree OR clinical prediction rule OR clinical pre-
diction score OR clinical decision rule OR clinical deci-
sion score OR management studies OR outcome studies
OR ICU admission OR ICU need OR invasive manage-
ment OR severity assessment). The search was performed
for articles in English, French, Italian, Spanish, and Ger-
man languages and limited to articles with an abstract
and completed on the first of March 2012. To ensure a
comprehensive literature search, we examined reference
lists from retrieved articles and reference literature
(guidelines and systematic reviews) and questioned
experts in CAP for possible missing studies.
Study inclusion and data extraction
Eligible studies were prospective or retrospective studies
evaluating clinical prediction rules in adult immunocom-
petent patients with CAP to predict the need for ICU
admission, intensive treatment, or early mortality (< 14
days). The evaluation had to be performed during the
first 24 hours after hospital admission. Studies addressing
specific patient subgroups based on etiology or age were
excluded. A prediction rule was defined as the combina-
tion of two or more clinical or biologic markers. Four
investigators (CM, NG, SC, and OG) evaluated studies
for possible inclusion. All studies were evaluated inde-
pendently by at least two investigators. Nonrelevant stu-
dies were excluded based on title and abstract. For
potentially relevant studies, the full text was obtained,
and two investigators (CM, NG) independently assessed
study eligibility and extracted the data on study design,
patient characteristics, and outcomes. Disagreements
were resolved by consensus or by discussion with a third
reviewer (AP)
Quality assessment
We used modified quality criteria based on the guidelines
for assessing quality in prognostic studies [14]. Two
investigators (CM, NG) assessed study quality indepen-
dently. Each of six items was scored from 0 to 2. Studies
with a total quality score between 11 and 12 were consid-
ered “good,” between 9 to 10, “moderate,” and 8 or less
was considered “poor.”
Data analysis
For each score, the diagnostic performances (sensitivity,
specificity, likelihood ratios, and diagnostic odds ratios)
to predict different definitions of SCAP (ICU admission,
early death, or intensive treatment) at the usual cut-off
were pooled by using the method of the inverse of the
variance. Random effects were systematically introduced
[15]. Heterogeneity was measured by the I-square index
[16] and tested with the Cochran test. Potential heteroge-
neity factors were explored by subgroup analyses for the
Pneumonia Severity Index (PSI) (only score with more
than 10 studies). A sensitivity analysis was conducted to
check the robustness of the pooled sensitivities and speci-
ficities by removing each study, one by one. The R pack-
age “meta: Meta-analysis with R, version 1.6-1” was used
for these analyses. For the PSI and CURB-65 (Confusion,
Urea, Respiratory Rate, Blood pressure, Age > 65 years)
scores, a summary ROC curve was assessed by the
approach proposed by Moses et al. [17]. As several sensi-
tivities and specificities were reported in the studies at
different cut-offs, we used a linear mixed model with a
correlation structure to take the dependence of the mea-
sures into account. The 95% confidence intervals of the
areas under the curves were obtained by bootstrap. This
analysis was performed with S-plus 8.0 for Windows.
The significance level was 0.05 for all analyses. Forest
plots of the Sensibility and Specificity were used for the
graphic display of the results.
Results
The search retrieved a total of 5,249 references, among
which 1,005 duplicates were identified. Of the 4,244
remaining articles, 3,966 were excluded based on title
and abstract (Figure 1). Full texts were obtained for the
remaining 278 articles. Ten did not contain original data,
13 concerned only ICU patients, 204 did not meet inclu-
sion criteria, 18 were review articles, and 33 satisfied
inclusion criteria. Three articles [18-20] were identified
by manual search of the references, leading to a total of
36 included articles [5,10-12,18-50]. Main characteristics
of included studies are detailed in Table 1.
Scores
We identified 11 main severity scores based on 20 vari-
ables. Components of the main severity scores are illu-
strated in Figure 2. Sufficient data were available to
perform a meta-analysis on eight scores: PSI, CURB-65,
CRB-65 (Confusion, Respiratory Rate, Blood pressure, Age
> 65), CURB (Confusion, Urea, Respiratory rate, Blood
pressure), ATS 2001 criteria, ATS/Infectious Disease
Society of America (IDSA) 2007 criteria, SCAP score
(Severe Community-Acquired Pneumonia), and SMART-
COP (Systolic Blood pressure, Multilobar infiltrate,
Albumin, Respiratory Rate, Tachycardia, Confusion, low
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Oxygen, low PH) (Table 2) Score definitions are included
in the Additional file 1. Forrest plots for specificity and
sensitivity of the eight scores for the prediction of ICU
admission are provided in Additional file 2.
PSI
Twenty-four studies [5,18,19,21,22,24-26,32,34,36,39-52],
including 20,622 patients and 2,073 ICU admissions
(10.1%), evaluated the performance of PSI to predict ICU
need. A PSI score category of IV or more had a pooled
sensitivity of 75% and a specificity of 48%. A cut-off of V
increased specificity to 84% and decreased sensitivity to
38%. The global performance of PSI to predict ICU admis-
sion was modest, with an AUC of 0.69 (Figure 3). Signifi-
cant heterogeneity was present. Performance of PSI to
predict an alternative definition of SCAP, including mor-
tality, was superior, with a pooled sensitivity of 92.4% (CI,
89 to 95) and specificity of 56.2% (CI, 43 to 69) in four
cohorts including 3,195 patients [11,49].
CURB-65
CURB-65 was studied in nine cohorts [21,24,25,27,40,42,
47,49,50] including a total of 5,773 patients and 479 ICU
admissions (8.3%). At the usual cut-off value of 3 or more,
pooled sensitivity was 56%, and specificity, 74%. The global
performance of CURB-65 to predict ICU admission was
similar to PSI with an AUC of 0.69 (Figure 3). Significant
heterogeneity was present. The performance of CURB-65
to predict the need for ventilation or vasopressors was stu-
died in three publications [10,28,50] including 2,951
patients, 264 requiring intensive treatment. Results were
similar, with a pooled sensitivity of 57.2% (CI, 37 to 75)
and specificity of 77.2% (CI, 73 to 81).
CRB-65
CRB-65 is a simplified version of the CURB-65 including
only clinical predictors. Two studies [40,50] including
2,078 patients and 122 ICU patients (5.8%) calculated the
performance of CRB-65 to predict ICU admission. For a
threshold of 3 or more, pooled sensitivity was 34%, and
specificity, 91%.
CURB (original BTS rule)
Performance of CURB to predict ICU admission was stu-
died in four cohorts [24,25,32,38] totaling 1,418 patients
and 161 ICU admissions (12.1%). Pooled sensitivity of a
CURB score of 2 or more to predict ICU admission was
76.8%, and specificity, 68.6%. Significant heterogeneity was
observed.
ATS 2001
The original ATS criteria for severe CAP published in
1993 [7] included 10 criteria. Some of these criteria were
assessed at admission, and others, at any time during clini-
cal course, limiting their use as a prediction rule. A new
set of criteria was proposed by Ewig in 1998 [33] and
adopted by the ATS in 2001. This prediction rule consists
of two major (mechanical ventilation or shock) and three
minor criteria (blood pressure < 90 mm Hg at admission,
PaO2/FiO2 < 250 mm Hg, and multilobar involvement on
chest radiograph). The prediction rule is considered posi-
tive in the presence of one major or two minor criteria.
We identified eight studies [5,22,24,32,33,39,40,45,49]
including a total number of 7,116 patients with 908 ICU
admissions (12.8%). The pooled sensitivity was 69.5%, and
specificity, 90.1%. Pooled AUC could not be calculated
because of insufficient data. Performance of the 2001 ATS
criteria in comparison with PSI and CURB-65 is illustrated
in Figure 4. A supplementary study [11] validated this rule
to predict a composite definition of SCAP (in-hospital
death, mechanical ventilation, or shock) in three cohorts
including 2,897 patients and 252 SCAP (8.7%). Pooled sen-
sitivity of the ATS 2001 criteria was 52.7%, and specificity,
95.1%. One study validated the use of the ATS 2001 minor
criteria on a cohort excluding patients with therapeutic
limitations or major criteria [50]. Sensitivity and specificity
of two or more minor criteria to predict ICU admission
were 47% and 91%.
ATS-IDSA 2007
A new prediction rule was proposed by the ATS and the
Infectious Disease Society of America (IDSA) in 2007.
This rule, known as the ATS-IDSA rule, consists of two
major (mechanical ventilation or shock) and nine minor
criteria (Figure 2). The rule is considered positive in the
presence of one major or three minor criteria. We found
five publications evaluating this rule [23,39,42,49,50].
Two studies, including 2,400 patients and 266 ICU
patients (11%), validated the original rule to predict ICU
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Figure 1 Study flow chart.
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2008 PSI/CURB-65 ICU admission 10.50% Uni R H 408 Included n
Angus 2002 PSI/ATS 2001/ATS 1993/URB ICU admission 12.70% Multi P H 1,339 Included n
Brown 2009 IDSA-ATS 2007/SMART-COP/CURB-65/SCAP IT in ICU/IT/ICU
admission
12.35% Uni R A+H 2,413 Excluded n
Buising 2006 PSI/ATS 2001/CURB/CURB-65 ICU admission/
death or ICU
6.60% Uni P A+H 392 Included n
Buising 2007 PSI/CURB/CURB-65/CORB Vent/vaso ICU 6.30% Uni P A+H 330 Included n
Calbo 2004 PSI ICU admission 3.30% Uni P H 362 Included n
Capelastegui 2006 CURB-65 ICU admission 4.09% Uni R H 1,100 Included n
Chalmers 2008 CRB-65/CURB-65 Vent/vaso 10.20% Multi P A+H 1,007 Excluded n
Chalmers 2011 IDSA-ATS 2007/SMART-COP/CURB-65/SCAP/





Uni P H 1,062 Excluded y
Charles 2008 SMART-COP/CURB-65/PSI Vent/vaso 10.30% Multi P A+H 882 Included n
Davis 2010 SMART-COP/SMARTACOP Vent/vaso 21.00% Uni P H 184 Excluded n
Escobar 2008 Abbreviated PSI ICU admission 12.30% Uni R H 6,147 Included n
Espana 2006 ATS 2001/PSI/CURB-65/SCAP Death, vent, or
septic shock
7.10% Uni P A+H 1,057 Included n
Death, vent or
septic shock
5.90% Uni P A+H 719 Included n
Death, vent or
septic shock
11.9% Multi R H 1,121 Included n
Espana 2010 SCAP/PSI/CURB-65 ICU admission NA Multi R H 712 Included n
Ewig 2000 PSI ICU admission 9% Uni P H 232 Included n
Ewig 2004 ATS 2001/PSI/CURB/CRB/URB/ ICU admission 16.70% Uni p H 696 Excluded n
Ewig 1998 ATS 1993/ATS 2001 ICU admission 16% Uni p H 332 Excluded n
Feagan 2000 PSI ICU admission 13.60% Multi r H 858 Included n
Frei 2004 SBP/pH/O2 saturation/pulse ICU admission 17% Uni r H 782 Included n







Uni p H 505 Excluded n
Garcia-Vidal 2008 PSI Early death 2.3% Uni p H 2,457 Included
Garau 2008 PSI ICU admission 5% Multi r H 3,233 Included n
Kamath 2003 CURB ICU admission 10% Uni p H 100 Excluded n
Lamy 2004 PSI ICU admission 14% Uni r H 152 Included n
Liapikou 2009 IDSA-ATS 2007/ATS 2001/PSI ICU admission 11% Uni p H 2,102 Excluded n(y)













Table 1 Main characteristics of included studies (Continued)
Marrie 2007 PSI/CURB-65 ICU admission 10% Multi p H 3,675 Included n
Neill 1996 CURB Mortality and
ICU
11% Uni p H 251 Excluded n
Phua 2009 PSI/CURB-65/IDSA-ATS 2007 ICU admission 15% Uni p H 1,017 Excluded y
Putinati 2003 PSI ICU admission 10% Uni p H 229 Included n
Renaud 2007 PSI ICU admission 3.70% Multi p H 566 Included n
PSI ICU admission 10.50% Multi p H 761 Included n
Renaud 2009 REA-ICU Early ICU
admission < 3
4.40% Multi p A+H 4,593 Excluded y
Restrepo 2008 PSI/ATS 2001 ICU admission 19.90% Multi r H 730 Excluded n
Riley 2004 ATS 2001/PSI ICU admission 23.69% Uni r H 498 Excluded n
Roson 2001 PSI ICU admission 8% Uni p H 533 Included n
Shah 2010 CURB-65/PSI ICU admission 23.30% Uni p A+H 150 Included n
Van der
Eerden
2004 PSI ICU admission 8.00% Uni p H 260 Included n













Four studies [23,39,42,50] evaluated the performance of
the minor criteria in a total of 6,412 patients including
650 ICU patients (10.1%). Pooled sensitivity was 57%,
and specificity, 90%. Significant heterogeneity was pre-
sent. Performance of the 2007 ATS-IDSA rule in com-
parison with PSI and CURB-65 is illustrated in Figure 4.
SMART-COP
Charles et al. [10] developed a prediction rule based on
eight weighted criteria (see Additional File 1). This rule
was validated in five external cohorts of pneumonia
patients and further adapted and validated in two
cohorts [29,50]. Pooled sensitivity of SMART-COP to
predict the need for vasopressors or mechanical ventila-
tion was 79%, and specificity, 68%.
Two studies evaluated this rule to predict ICU admis-
sion [49,50], with a pooled sensitivity of 79% and specifi-
city of 64% on 1,567 patients including 112 ICU
admissions (7.1%).
SCAP score
Espana et al. [11] derived and validated a prediction rule
based on eight weighted criteria (see Additional File 1).
Pooled performance of this rule on three cohorts totaling
3,402 patients (SCAP, 9%) to predict a composite defini-
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CURB-65                     
CRB-65                     
CURB                     
CORB                     
ATS 1993                     
ATS 2001                     
ATS/IDSA 
2007 
                    
SMART-
COP 
                    
SCAP                     
REA-ICU                     
Figure 2 Components of the main severity scores. Criteria used in the score appear as shaded areas. BP, blood pressure; HR, heart rate; RR,
respiratory rate; T, temperature.
Table 2 Operative characteristics of the principal scores to predict ICU admission at their usual cut-off (95% CI)
Sensitivity Specificity NLR PLR DOR
PSI ≥ 4 75.0 (71-78) 48.0 (44-52) 0.53 (0.46-0.6) 1.5 (1.4-1.6) 2.9 (2.4-3)
CURB-65 ≥ 3 56.2 (41-70) 74.2 (68-79) 0.64 (0.51-0.79) 2.1 (1.6-2.7) 3.6 (2.2-5.8)
CRB-65 ≥ 3 34.2 (18-55) 90.6 (89-92) 0.72 (0.54-0.97) 3.6 (1.9-6.9) 5.0 (2.0-12.7)
CURB ≥ 2 76.8 (48-92) 68.6 (53-81) 0.35 (0.18-0.70) 2.3 (1.9-2.7) 5.5 (3.7-8.2)
ATS 2001 69.5 (61-77) 90.1 (82-95) 0.37 (0.30-0.46) 7.3 (4.4-12.2) 24.6 (13.1-46.4)
ATS 2007 83.8 (48-97) 77.7 (46-93) 0.22 (0.08-0.66) 3.8 (1.7-8.6) 17.6 (13.1-24.1)
ATS 2007a 57.0 (46-68) 90.5 (84-95) 0.48 (0.38-0.6) 5.9 (3.8-9.3) 13.1 (7.7-22.3)
SCAP 93.8 (88-97) 45.6 (27-66) 0.13 (0.06-0.26) 1.8 (1.2-2.6) 14.9 (6.7-33.1)
SMART-COP 79.0 (69-87) 64.2 (30-66) 0.15 (0.03-0.91) 2.6 (1.3-5.3) 14.9 (8.6-25.7)
DOR, diagnostic odds ratio; NLR, negative likelihood ratio; PLR, positive likelihood ratio. aMinor criteria.
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or shock) was 92% (0.83 to 0.97) for sensitivity and 64%
(0.5 to 0.76) for specificity.
Pooled performance of the SCAP score to predict ICU
admission in two recent cohorts [49,50] was similar in
terms of sensitivity (94%) but lower regarding specificity
(46%)
Other scores
Renaud et al. [12] proposed a prediction rule (REA-ICU
index) based on 11 predictors (see Additional File 1).
This rule was derived to predict early ICU admission
(day 1 to day 3), excluding patients with an obvious ICU
indication at admission and patients with therapeutic
limitations (not to be resuscitated, NTBR order) and vali-
dated on four North American and European prospective
multicenter cohorts including 6,560 patients. AUC was
0.81 (CI, 0.78 to 0.83) on the overall population.
An abbreviated version of the PSI was tested on an











































































































































































































































Figure 3 SROC curve and area under the curve (AUC) of Pneumonia Severity Index (PSI) and CURB-65 to predict ICU admission.
Individual studies are represented by a number indicating the cut-off used. Their place on the diagram represents the sensitivity and specificity





























































































































Figure 4 Pooled discriminative performance of the principal
scores for severe CAP compared with Pneumonia Severity
Index (PSI) and CURB-65 ROC curve.
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to modify the CURB rule to include an oxygenation para-
meter [25] (CORB). These scores have not been validated
in other cohorts.
Quality assessment and sources of heterogeneity
We completed quality assessment according to the cri-
teria developed by Hayden et al. [14].
Nine studies were considered good (scores ≥ 11); 23,
moderate (9 to 10); and four poor (≤ 8) quality (see
Additional file 3). Important differences were observed
in terms of design, populations, and ICU admission
rates. Twenty-nine studies included only hospitalized
patients, and seven included both hospitalized and
ambulatory patients. Patients with therapeutic limita-
tions (NTBR order) were excluded in 15 of 36 studies,
and patients with an obvious indication for ICU, in
three [12,42,47]. ICU admission rate varied from 3.3%
[26] to 23.9% [45], and receipt of intensive treatment in
the ICU was highly variable (16% to 100% [25,33]).
When multiple measures of the same variable were
available, as for vital signs, the measure introduced into
the prediction rule was the first available one in four
studies, the most abnormal one in five, and not specified
in the majority of studies.
We performed an analysis to identify sources of hetero-
geneity for the only score (PSI) evaluated in at least 10
studies. Analyses did not reveal any significant factor of
heterogeneity for sensitivity. Three factors influenced
specificity: inclusion of NTBR patients decreased specifi-
city; studies of good quality or high prevalence (≥ 15%)
showed higher specificity. Nevertheless, the NTBR factor
is highly correlated with the quality of the study (the
NTBR patients were more frequently excluded in high-
quality studies) and the prevalence (NTBR patients were
more frequently excluded in studies with a high preva-
lence). NTBR exclusion is suspected to be the main fac-
tor explaining the heterogeneity observed in the
specificity. The association between specificity and preva-
lence or quality may be caused by the correlation with
NTBR exclusion.
Sensitivity analysis showed that the conclusions of the
meta-analyses were robust and not caused by a single
study. Sensitivity and specificity did not vary by more
than 10%, except for CURB score: the study by Ewig [32]
has a lower sensitivity and higher specificity than do
other studies, but only four studies were included in this
analysis.
Discussion
In this systematic review of clinical prediction rules to
predict severe CAP, PSI and CURB-65 have similar per-
formances to identify patients requiring ICU admission.
A PSI score of 4 or more is more sensitive (75% versus
56%) but less specific (47% versus 74%) than a CURB-65
score of 3 or more. These two scores, derived and vali-
dated to predict 30-day mortality, perform poorly to pre-
dict ICU admission, with an estimated AUC of 0.69. This
performance is inferior to their original application: AUC
for prediction of 30-day mortality was 0.80 in a recent
systematic review [53].
Some explanations are available for this difference.
These prediction rules, and especially the PSI, are heavily
weighted by comorbidities and age and tend to consider
as severe, patients in whom CAP is a terminal event.
In many cohorts, the mortality rate is higher than the
ICU admission rate, suggesting that an important pro-
portion of patients with CAP die without being consid-
ered for ICU admission [21,39]. Age, a major component
of these scores, is often negatively associated with ICU
admission or intensive treatment [12,25,41] Exclusion of
patients with therapeutic limitations may improve the
specificity of these scores for ICU admission. In our het-
erogeneity analysis, PSI specificity increased from 45% to
56% when studies including NTBR patients were
excluded (P = 0.008).
A new generation of scores, specifically developed to
predict ICU admission, focuses on the severity of the
pneumonia itself rather than on age and comorbid con-
ditions. Overall, the performance of these scores seems
superior to that of the PSI or CURB-65, particularly
regarding specificity (90.1% and 90.5% for the ATS 2001
score and ATS/IDSA 2007 minor criteria versus 48.0%
and 74.2% for PSI and CURB-65).
When considering scores derived over time, secular
trends must be considered. Use of noninvasive ventilation
(NIV) for severe CAP has increased over the last decade.
This might have changed the proportion of patients
receiving invasive mechanical ventilation. However, NIV
was explicitly included in the definition of mechanical
ventilation in most studies using that end point
[10,25,29]. As the efficacy of NIV in alleviating respira-
tory failure for CAP patients is still debated, NIV is unli-
kely to have induced a major bias in the performance of
the prediction rules over time. Furthermore, the principal
scores (SCAP rule, SMART-COP, ATS 2007, and REA-
ICU) have been proposed recently, at a time during
which NIV for respiratory failure was routinely used.
Inclusion of major criteria in the ATS rules (mechani-
cal ventilation and shock) improves their diagnostic per-
formance but is not useful clinically, because these
patients have an obvious indication for ICU admission.
However, use of the minor criteria only does not seem
to reduce the specificity of the ATS/IDSA 2007 score, as
suggested by our results, with a pooled specificity of
90.5%. In a recent prospective cohort excluding patients
with major criteria or therapeutic limitations, ATS-IDSA
minor criteria had an AUC of 0.85 to predict ICU
admission [50].
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SMART-COP, REA-ICU, and SCAP scores seem to
have operative characteristics similar to the ATS minor
criteria but are less extensively validated. Also, confi-
dence intervals are wide, and the use of different defini-
tions of severe CAP limits comparison. Not surprisingly,
these prediction rules share an important proportion of
their predictive variables, as illustrated in Figure 2. Use
of these three rules is more difficult than that of the
ATS minor criteria, because of the weighting of the dif-
ferent predictive factors and the use of age-adjusted cut-
offs.
Although the new generation of scores seems to have
enhanced operative characteristics to predict ICU
admission, their clinical utility is still debated. With a
10% prevalence of severe CAP and 57% sensitivity, even
a specificity of 91% (as reached by the ATS-IDSA 2007
minor criteria) will lead to a positive predictive value of
only 41%, leading to an important overuse of ICU
resources. High negative predictive value is the most
consistent finding among the different studies, suggest-
ing that these scores could be more relevant to exclude
the presence of a severe CAP than to aid in performing
triage in patients for ICU admission. However, this high
negative predictive value is mainly due to the low preva-
lence of severe patients. With a pooled sensitivity of
57%, the ATS-IDSA 2007 minor criteria would fail to
identify almost one half of the patients with severe CAP,
an unacceptably high proportion.
CAP is a complex and evolving inflammatory disease
and critical clinical deterioration can result from various
processes: respiratory failure, circulatory failure, destabili-
zation of a preexisting comorbidity, appropriateness of
initial antibiotic therapy, or hospital-acquired illnesses. It
is not surprising that no single clinical rule has sufficient
operating characteristics to be useful in this wide spec-
trum of evolution profiles.
The new generation of clinical prediction rules focuses
on the early detection of respiratory and circulatory fail-
ure. Inclusion of various biomarkers such as procalcito-
nin [54], endothelin-1 [55], co-peptin [56], pro-atrial
natriuretic peptide [57,58], or adrenomedullin [59] is
hoped to improve this detection. Nevertheless, these bio-
markers will probably fail to predict clinical deterioration
due to hospital-acquired complications or decompen-
sated comorbidities. It is even dubious whether they will
detect circulatory or respiratory failure in patients
admitted in the very early course of their disease.
In our view, rather than a definitive response to severity
assessment, clinical prediction rules in patients with CAP
should be considered an aid to clinical judgment particu-
larly useful for less-experienced clinicians. Some of the
included variables are consistently associated with a grim
evolution, and their identification in an individual patient
should alert for this possibility and trigger its timely
reassessment and a thorough evaluation for intensive
care or high-dependency-unit admission.
Strengths
Our review incorporates the most recent published stu-
dies and updates the systematic review by Chalmers
et al. [60]. We also used somewhat different inclusion
criteria and data analysis. We did not include subgroups
of patients based on age or pathogen, leading to the
noninclusion of three studies [61-63]. Among the 40
studies included in the two systematic reviews, 24 were
included in both, 12 in our work only, and four in the
study by Chalmers et al. only. We decided against
aggregating different definitions of SCAP, in an attempt
to limit heterogeneity, and computed the performances
of the prediction rules for the different definitions of
SCAP. We included large recent studies [49,50] and
could estimate the pooled performance of the more-
recent prediction rules, SMART-COP and SCAP score.
This allows direct comparison between recent prediction
rules. Although included studies differed partially
between our systematic review and that by Chalmers et
al., our final results are very similar, mutually strength-
ening their validity.
Limitations
An important limitation of systematic reviews is their
dependence on the quality of the included studies.
Although the majority of included studies were consid-
ered of good or moderate quality, several pitfalls remain
in the prediction of severe CAP. First, as already dis-
cussed, two biases are highly prevalent in these studies:
inclusion in the studied population of patients not at
risk for ICU admission (patients with therapeutic limita-
tions); and use as a predictor of a surrogate of the out-
come (use of mechanical ventilation and vasopressors,
which are universally delivered only in an intensive or
intermediate care unit).
Second, no universally accepted definition exists of
severe CAP. The most frequently used proxy, ICU
admission, is heavily influenced by ICU beds availability,
local ICU admission policy, or subjectivity of the ICU
specialist’s evaluation. Use of a subjective decision such
as ICU admission as a gold standard might lead to cir-
cular reasoning, because a perfect rule would be the one
fitting usual practice. However, alternative definitions of
SCAP, such as receipt of intensive treatment, do not
seem to modify importantly operative characteristics of
the prediction rules [23].
Third, definition of a “false positive” ICU admission is
unclear: some patients might benefit from ICU admis-
sion even if they are not receiving vasopressors or
mechanical ventilation (for example, through better fluid
resuscitation).
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Fourth, some of the studied rules have been fully
incorporated in expert society recommendations. This
might lead to contamination of ICU admission practices,
further leading to an overestimation of their accuracy.
Finally, major heterogeneity was present among
included studies, limiting the validity of the meta-
analysis.
Conclusions
PSI and CURB-65 do not have sufficient operating char-
acteristics to be useful for making ICU triage decisions
in severe CAP. Newer rules, specifically conceived to aid
in identifying severe CAP, perform better but still have
insufficient test characteristics to be a major help in
everyday decisions. Recent clinical prediction rules
should be considered an aid to clinical judgment to
guide ICU admission in CAP patients. Clinical trials
evaluating this issue should exclude patients who are
not candidates for ICU admission and predicting factors
that make ICU admission mandatory. Inclusion of new
biomarkers, dynamic reassessment of the severity scores,
and impact studies evaluating their use would deserve
evaluation in future clinical research.
Key messages
• Identification of severe community-acquired pneu-
monia (SCAP) should allow admission of patients at
the appropriate level of care.
• Traditional severity scores, the PSI and CURB 65,
perform poorly to identify patients requiring ICU
admission.
• New dedicated scores have better operative charac-
teristics and could be useful adjuncts to clinical
judgment.
Additional material
Additional file 1: Definition of the different scores. This file contains
the detailed components and cut-offs values of the different prediction
rules (PSI, CURB-65, ATS-2001, IDSA/ATS 2007, SCAP score, SMART-COP,
and REA-ICU).
Additional file 2: Forrest plots of sensitivity/specificity of the
different scores to predict ICU admission. This file contains the Forrest
plots of the eight meta-analyzed scores (PSI, CURB-65, CURB, CRB-65,
SMART-COP, SCAP score, ATS-2001, and IDSA/ATS 2007) for the outcome
ICU admission.
Additional file 3: Study quality assessment. Global and detailed
quality assessment for each included study is provided in this file.
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